Health ❯Healthcare ❯Neurology ❯Cognitive Disorders

Dementia

EMA Recommends Donanemab for Early Alzheimer’s in the EU

The recommendation imposes MRI screening to rule out vascular narrowing, capping eligibility at one copy of the ApoE4 gene.

Frequent Gabapentin Prescriptions Tied to Increased Dementia and Cognitive Impairment Risk

Parkinson’s Onset Side Predicts Divergent Cognitive and Mental Health Trajectories

FDA Approves First Blood Test for Alzheimer’s Diagnosis

EU Drug Agency Recommends Approval of First Alzheimer’s Treatment Targeting Disease Progression

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

GLP-1 Drug Shows Promise in Slowing Alzheimer's Cognitive Decline